Healthcare stocks jump after Republicans unveil plan; banks, staples slip
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Accenture plc (ACN) PT Raised to $130 at BMO Capital on 3Q Report; 'Story & Opportunity Remain Fairly Steady'
June 23, 2017 9:26 AM EDTBMO Capital raised its price target on Accenture plc (NYSE: ACN) to $130.00 (from $125.00) while maintaining a Market Perform rating, following the company's third quarter earnings report.
Analyst Keith Bachman notes the company delivered in-line third quarter earnings per share results, while offering revenues above... More
Oracle (ORCL) PT Raised to $56 at Canaccord Genuity on 4Q Beat; 'Expects PaaS & IaaS Business to Enter Hyper-Growth in F18'
June 22, 2017 10:58 AM EDTCanaccord Genuity raised its price target on Oracle (NYSE: ORCL) to $56.00 (from $49.00) while maintaining a Buy rating, following the company's fourth quarter earnings announcement.
Analyst Richard Davis notes the company delivered fourth quarter earnings per share, revenues and margins above consensus projections... More
Oracle (ORCL) PT Raised to $52 at UBS Following 4Q
June 22, 2017 9:18 AM EDTUBS raised its price target on Oracle (NYSE: ORCL) to $52.00 (from $48.00) while maintaining a Buy rating following the company's 4Q earnings report.
The standout highlights from ORCL's 4Q was the $500M revenue beat and +200bps of margin upside, which combined delivered ~7c of EPS outperformance.
... MoreOracle (ORCL) PT Raised to $57 at BMO Capital on 4Q Beat; 'Strong Performance was Broadly Based'
June 22, 2017 8:58 AM EDTBMO Capital raised its price target on Oracle (NYSE: ORCL) to $57.00 (from $48.00) while maintaining a Outperform rating, following the company's fourth quarter announcement.
Analyst Keith Bachman notes the company delivered fourth quarter earnings per share, revenues and operating margins above consensus projections... More
Oracle (ORCL) PT Raised to $48 at Deutsche Bank Following 4Q
June 22, 2017 7:39 AM EDTDeutsche Bank raised its price target on Oracle (NYSE: ORCL) to $48.00 (from $44.00) while maintaining a Hold rating.... More
